Positive on Sun Pharma, says Ajay Bodke

Ajay Bodke of Prabhudas Lilladher told CNBC-TV18, "We are positive on Sun Pharmaceutical Industries. Our believe always was that almost all the negative has been priced in if the first quarter numbers, the large one time hit that they have taken. We were looking forward to what happens to approvals on Halol plant. So, once we are over that hump the stock in our view should rally strongly. On a medium-term basis we would look at Sun Pharma."At 11:38 hrs Sun Pharmaceutical Industries was quoting at Rs 884, up Rs 17.30, or 2 percent. It has touched an intraday high of Rs 889.95 and an intraday low of Rs 876.30.